Similarly, romidepsin (or istodax), a natural product obtained from the Gram-negative bacteria Chromobacterium violaceum, has also shown anti-HDAC properties and is currently approved for the treatment of other cancers like T-cell lymphomas. This evidence concerns the gene HDAC9 and cancer.